Berger, M. G., Lebecque, B., Tassin, T., Dannus, L., Berger, J., Soucal, M., . . . Bourgne, C. (2021). Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34− and immature CD34+ cells. Nature Portfolio.
Chicago Style (17th ed.) CitationBerger, Marc G., et al. Efficiency of Nilotinib to Target Chronic Phase-chronic Myeloid Leukaemia Primary Mature CD34− and Immature CD34+ cells. Nature Portfolio, 2021.
MLA (8th ed.) CitationBerger, Marc G., et al. Efficiency of Nilotinib to Target Chronic Phase-chronic Myeloid Leukaemia Primary Mature CD34− and Immature CD34+ cells. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.